Skip to main content

AETHLON MEDICAL INC

For the period ended Mar 31, 2026. Filed Jun 10, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2026 · Filed Jun 10, 2026

AEMD$5.49+0.4%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated Balance Sheets

March 31,
20262025
ASSETS
CURRENT ASSETS
Cash and cash equivalents$5,026,458$5,501,261
Deferred offering costs210,985–
Prepaid expenses and other current assets332,094448,539
TOTAL CURRENT ASSETS5,569,5375,949,800
Property and equipment, net356,822676,220
Operating lease right-of-use asset, net307,820601,846
Patents, net–550
Restricted cash98,92897,813
Deposits–33,305
TOTAL ASSETS$6,333,107$7,359,534
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES
Accounts payable$384,550$534,524
Due to related parties68,250579,565
Operating lease liability, current portion336,718313,033
Other current liabilities657,317472,164
TOTAL CURRENT LIABILITIES1,446,8351,899,286
Operating lease liability, less current portion–336,718
TOTAL LIABILITIES1,446,8352,236,004
COMMITMENTS AND CONTINGENCIES (Note 8)––
STOCKHOLDERS’ EQUITY
Common stock, $0.001 par value, 100,000,000 shares authorized at March 31, 2026 and 6,000,000 shares authorized at March 31, 2025; 1,570,449 issued and outstanding at March 31, 2026 and 258,531 shares issued and 201,074 outstanding at March 31, 20251,570259
Additional paid-in capital180,023,691173,095,221
Accumulated other comprehensive loss(32,703)(17,133)
Accumulated deficit(175,106,286)(167,954,817)
TOTAL STOCKHOLDERS’ EQUITY4,886,2725,123,530
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY$6,333,107$7,359,534
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.